The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the use of testosterone treatment in healthy women. Although the FDA approved testosterone therapy for the treatment of ailments involving the testes, pituitary and hypothalamus, it hasn’t been approved for treating age-associated decrease in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the safety of testosterone. The study involved about 800 older men with low testosterone and symptoms related to this illness, including anti aging supplements for men (tinyurl.com) sexual and physical dysfunction. The research is expected to shed more light on the security of testosterone treatment, since the men’s heart health was carefully monitored.
Studies have shown that testosterone deficiency is related to a number of critical health problems like diabetes, obesity, metabolic syndrome, and bone fractures Guys who meet medical standards for treatment should receive therapy. In fact, your testosterone levels have likely been slowly decreasing for quite some time, a downfall that usually begins around age 30.
No clear lower limit of testosterone has been confirmed; nevertheless 15 ng per dL (0.5 nmol per L) typically is used. One study 38 found that girls with 0 to 10 ng per dL (0 to 0.3 nmol per L) had markedly decreased sexual desire in all scenarios and absent or markedly decreased orgasms. As a result of studies like this, supplemented with anecdotal evidence, many women are started on testosterone therapy. Most women can expect to spend one third of their lives in the postmenopausal period. Depression, rage, moodiness, insomnia, and lack of well-being are common complaints of postmenopausal women.